If you have been reading about freeze-thaw cycling and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-08. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | N-terminal fragment of thymosin beta-4 |
| Residue count | Seven | Sequence LKKTETQ |
| Approximate mass | 889 Da | Acetylated seven-residue peptide |
| Common synonyms | TB4 fragment, TB500 | Not identical to full-length TB4 |
| Reported activity | Actin binding | Observed mainly in cell-free systems |
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
The shallot ( or ) is a cultivar group of the onion. Until 2010, the (French red) shallot was classified as a separate species, Allium ascalonicum. The taxon was synonymized with Allium cepa (the common onion) in 2010, as the difference was too small to justify a separate species. As part of the onion genus Allium, its close relatives include garlic, scallions, leeks, chives, and the Chinese onion.
=== Efficacy === There is an average 52% decrease in inflammatory acne lesions by week 12. The combination is less effective than benzoyl peroxide/salicylic acid after short-term treatment of two to four weeks, but the two treatments showed similar effectiveness after ten to twelve weeks.
In August 2020, it was announced that Jensen Ackles would be joining the show as Soldier Boy, promising that "the character would bring so much humor, pathos, and danger to the role." Laura Jean Shannon designed the suit for the character using military green and referring to him as "the original bad-ass". She eventually explained how the suit fits his character: "Our goal was to highlight a bygone era of overt masculinity and grit. With that pedigree we dove headfirst into baking in an all-American quality grounded in a military soldier's practicality with a heavy dose of old school cowboy swagger. We knew that the actor had to have Steve McQueen looks and chops with a John Wayne attitude — luckily Jensen Ackles embodies all of that." In October 2020, it was announced that Claudia Doumit and Colby Minifie would reprise their roles as Victoria Neuman and Ashley Barrett respectively, with both being promoted to series regulars. In March 2021, it was announced that Katia Winter was cast as the Russian mob boss Little Nina. That June, Miles Gaston Villanueva, Sean Patrick Flannery, Nick Wechsler and Laurie Holden were cast as Supersonic, Gunpowder, Blue Hawk, and Crimson Countess respectively. In October 5, Jack Doolan, Kristin Booth, and Frances Turner joined the series with Booth and Dooland appearing as the TNT Twins with the former being Tessa TNT and the latter being Tommy TNT, while Turner replaces Alvina August as MM's ex-wife Monique.
Sources: en.wikipedia.org
=== Knoxville in the 1960s === In 1960, several Knoxville College students, led by Robert Booker and Avon Rollins, engaged in a series of sit-ins to protest segregation at lunch counters in Downtown Knoxville. This action prompted downtown department stores to desegregate, and by the end of the decade, most other downtown businesses had followed suit. City schools also gradually desegregated during this period, largely in response to a lawsuit brought by Josephine Goss in 1959. Between 1945 and 1975, the University of Tennessee's student body grew from just under 3,000 to nearly 30,000. The school's campus expanded to cover the entire area between Cumberland Avenue and the river west of Second Creek, and the Fort Sanders neighborhood was largely converted into student housing. By the mid-1970s, U.T. employed over 4,000 faculty and staff, providing a boost to the city's economy. The growing popularity of the school's sports teams led to the expansion of Neyland Stadium, one of the largest non-racing stadiums in the nation, and the eventual construction of Thompson–Boling Arena, one of the largest basketball venues in the nation at the time of its completion. While unemployment declined to just 2.8% in the 1960s, many of the jobs paid low wages, stunting the growth of the city's service sector. Large parts of the downtown area continued to deteriorate, and nearly half of all houses in the city's older neighborhoods were considered substandard and in a critical state of decline.
Association for Molecular Pathology v. U.S Food and Drug Administration (FDA) The U.S. Food and Drug Administration (FDA) issued a final rule on May 6, 2024, to regulate laboratory-developed test (LDT) as medical devices and to oversee clinical laboratories as manufacturers of medical device. This rule would have increased reporting requirements by clinical laboratories, including registration for FDA premarket approval before launching new LDTs. AMP opposed this legislation and filed a lawsuit against the FDA in August 2024, citing concerns with the negative impact on patient access to LDTs and on laboratory innovation, as well as the expected increased costs of LDTs. On May 31, 2025, a U.S. federal court vacated this rule in favor of AMP and the American Clinical Laboratory Association, which had filed a separate lawsuit against the FDA. The court ruled that the regulation of LDTs as medical device “defies bedrock principles of statutory, common sense and longstanding industry practice” and that “Congress had already considered issues raised by LDTs in CLIA and had given the CMS regulatory authority over LDTs, not the FDA.” The FDA rule was officially withdrawn in September 2025.
== In popular culture == Dover's powder was part of a joke published in The Science of Health in 1875 and reprinted in Godey's Lady's Book the same year. The joke illustrates its status as a typical medicine for a tumor:An old lady in Jefferson County acquired the habit of using morphia for relief from the pains of a tumor. Her family vainly dissuaded her, and at last united in deceiving her by substituting carefully prepared potato starch in morphia bottles. She used this article for fifteen years until the day of her death, often complaining that it was an inferior article, though her physician declared it all right. He gave her Dover's powders once during an illness, but she could not rest until she took some of the starch morphia.
Carbohydrate antigens on the surface of cells can be used as targets for immunotherapy. GD2 is a ganglioside found on the surface of many types of cancer cell including neuroblastoma, retinoblastoma, melanoma, small cell lung cancer, brain tumors, osteosarcoma, rhabdomyosarcoma, Ewing's sarcoma, liposarcoma, fibrosarcoma, leiomyosarcoma and other soft tissue sarcomas. It is not usually expressed on the surface of normal tissues, making it a good target for immunotherapy. As of 2014, clinical trials were underway.
Sources: en.wikipedia.org
=== Beneficial effects === UV (specifically, UVB) causes the body to produce vitamin D, which is essential for life. Humans need some UV radiation to maintain adequate vitamin D levels. According to the World Health Organization:
=== Neural sources === In the hypothalamus, oxytocin is made in magnocellular neurosecretory cells of the supraoptic and paraventricular nuclei, and is stored in Herring bodies at the axon terminals in the posterior pituitary. It is then released into the blood from the posterior lobe (neurohypophysis) of the pituitary gland. These axons (likely, but dendrites have not been ruled out) have collaterals that innervate neurons in the nucleus accumbens, a brain structure where oxytocin receptors are expressed. The endocrine effects of hormonal oxytocin, and the cognitive or behavioral effects of oxytocin neuropeptides are thought to be coordinated through its common release through these collaterals. Oxytocin is also produced by some neurons in the paraventricular nucleus that project to other parts of the brain and to the spinal cord. Depending on the species, oxytocin receptor-expressing cells are located in other areas, including the amygdala and bed nucleus of the stria terminalis. In the pituitary gland, oxytocin is packaged in large, dense-core vesicles, where it is bound to neurophysin I as shown in the inset of the figure; neurophysin is a large peptide fragment of the larger precursor protein molecule from which oxytocin is derived by enzymatic cleavage. The electrical activity of the oxytocin cells in the hypothalamus regulates the secretion of oxytocin from the neurosecretory nerve endings.
=== Mental health === Mental health side effects have been reported. These symptoms are rare but exist in significant enough numbers to include as potential side effects. These include depression, anxiety, irritability, nightmares, and psychotic reactions.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.
The fragment contains an actin-binding motif, and cell-free experiments show that it can interact with monomeric actin. That observation is the basis for interest in cell migration and repair processes. Effects reported in animals are not established for humans.
Purity is usually stated by the supplier rather than fixed by a pharmacopoeial monograph, and typical listings report a percentage from reverse-phase HPLC. Independent verification is uncommon. Because no single accepted specification exists, comparisons between lots and between suppliers are difficult.
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.